HCMT
BIO icon

Highland Capital Management (Texas)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Highland Capital Management (Texas)’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-20,000
Closed -$6.11M – 324
2019
Q1 		$6.11M Buy
+20,000
New +$5.4M 0.38% 55

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Highland Capital Management (Texas)'s BIO Position: Q2 2019 in Review

Highland Capital Management (Texas) reduced its Bio-Rad Laboratories Class A (BIO) stake by 71% in Q2 2019, selling an estimated $4.49M and leaving 6,020 shares worth $1.88M. The position accounts for 0.11% of the portfolio, ranked #160.

Highland Capital Management (Texas) first reported a position in BIO in Q3 2013 and has held it in 13 quarters since. The position peaked at $23.7M in Q2 2018. 330 funds tracked by Wall St. Rank hold BIO as of Q2 2019.

  • Highland Capital Management (Texas) held 6,020 shares of Bio-Rad Laboratories Class A worth $1.88M as of Q2 2019.
  • Highland Capital Management (Texas) sold 15,000 Bio-Rad Laboratories Class A shares in Q2 2019, an estimated $4.49M.
  • Bio-Rad Laboratories Class A made up 0.11% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #160 holding.
  • Highland Capital Management (Texas) first reported a position in Bio-Rad Laboratories Class A in Q3 2013 and has held it in 13 quarters since.
  • Highland Capital Management (Texas)'s Bio-Rad Laboratories Class A position peaked at $23.7M in Q2 2018.
  • 330 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.